BRAF in Melanoma: Answering Questions, Addressing Misconceptions
In the resources provided below, the AIM at Melanoma Foundation provides answers to questions and addresses misconceptions raised by patients regarding BRAF in melanoma. The patient-directed resources address what BRAF is, the role of BRAF in melanoma, what BRAF mutational status means, testing for BRAF, and the implications of the test results for treatment planning. The answers are provided by Lisa Kottschade, APRN, MSN, CNP, Associate Professor of Oncology at the Mayo Clinic in Rochester, Minnesota, and an expert faculty member of the Melanoma Nursing Initiative.
We thank Novartis Pharmaceuticals for an unrestricted educational grant in support of this important educational initiative.